Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China flag China · Delayed Price · Currency is CNY
31.02
+0.60 (1.97%)
At close: Mar 10, 2026
135.00%
Market Cap 6.08B
Revenue (ttm) 1.45B
Net Income (ttm) 108.09M
Shares Out 196.11M
EPS (ttm) 0.54
PE Ratio 57.52
Forward PE n/a
Dividend 0.20 (0.66%)
Ex-Dividend Date Nov 24, 2025
Volume 3,646,162
Average Volume 4,466,413
Open 30.70
Previous Close 30.42
Day's Range 30.50 - 31.13
52-Week Range 11.44 - 68.80
Beta 0.87
RSI 42.17
Earnings Date Apr 29, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 1,275
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002940
Full Company Profile

Financial Performance

In 2024, SHE:002940's revenue was 1.51 billion, a decrease of -6.63% compared to the previous year's 1.62 billion. Earnings were 80.33 million, a decrease of -41.94%.

Financial Statements

News

There is no news available yet.